TABLE 6.
THE ASSOCIATION OF TOP BIOMARKER GWAS SNPs WITH RISK OF COPD IN THE COMBINED COLLABORATIVE COPD GWAS MEGA-ANALYSIS
Protein | CHR | SNP | BP | Nearest Gene | Minor Allele | Test | OR | 95% CI | P* |
CC16 | 11 | rs17157266 | 61956393 | AHNAK | C | ADD | 1.20 | 1.05 to 1.37 | 0.008 |
Surfactant protein D | 16 | rs8063863 | 82958351 | ATP2C2 | T | ADD | 0.80 | 0.70 to 0.92 | 0.001 |
16 | rs8048576 | 82980535 | ATP2C2 | A | ADD | 0.82 | 0.71 to 0.95 | 0.008 | |
10 | rs7078012 | 81695413 | SFTPD | T | ADD | 0.84 | 0.73 to 0.97 | 0.017 | |
10 | rs1885553 | 81701691 | SFTPD | C | ADD | 1.11 | 1.00 to 1.24 | 0.049 | |
10 | rs1923539 | 81684930 | RP11-479O17.4 | A | ADD | 1.13 | 1.00 to 1.27 | 0.043 |
Definition of abbreviations: BP = physical position (base-pair); CC16 = Clara cell secretory protein; CHR = chromosome; CI = confidence interval (lower, upper); COPD = chronic obstructive pulmonary disease; GWAS = genome-wide association study; OR = odds ratio; SNP = single nucleotide polymorphism.
Only SNPs with P < 0.05 are shown.
P values adjusted for age, pack-years of smoking, and 16 principal components for genetic ancestry.